ASAAN, Heartnet India's IoT-Based Cardiac Health Solution, is now Available
Written by Shaveta Arora
Heartnet India launches ASAAN, an IoT-based telecardiology solution, revolutionizing cardiac care accessibility nationwide, empowering patients and physicians alike.
Heartnet India launched ASAAN, an IoT-based telecardiology product that allows physicians to conduct cardiac health checks at their clinics. This innovative solution aims to bridge the gap between urban and rural areas, providing top-tier cardiac care at affordable costs.
Heartnet India will integrate telecardiology into its services in Karnataka, Maharashtra, and West Bengal starting in August. The initiative aims to make cardiac care accessible to tier 2, tier 3, and rural areas using IoT. Heartnet's ASAAN solution enables health checkups in any corner of the country, providing high-quality cardiac care to all regions.
Arindam Sen, CEO & Director, Heartnet India, says -
“The introduction of telecardiology reduces the amount of time it takes for doctors and patients to coordinate care, leading to better patient outcomes. This ensures high-quality care, since specialists can quickly review clinical data and make decisions about whether a test or treatment is necessary. It ultimately reduces the risk of incorrect decisions in cardiac diseases in remote areas. The initiative will be the cornerstone for healthcare in coming timings”
ASAAN will also grant cardiologists the capability to monitor their patients' health in real-time, enabling them to promptly recommend medications or lifestyle changes without requiring in-person office visits. This accelerated diagnosis and treatment process not only reduces the overall cost of care but also leads to improved patient outcomes and life-saving interventions.
Heartnet India has planned to expand its initiative in the next three quarters, starting with West Bengal, Karnataka, and Maharashtra in phase 1. Their target is to install approximately 1000 installations during the first year of operation. The product has already received approval from the Indian regulator, CDSCO.